Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial
Titel:
Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial
Auteur:
Kantarjian, Hagop M Fenaux, Pierre Sekeres, Mikkael A Szer, Jeffrey Platzbecker, Uwe Kuendgen, Andrea Gaidano, Gianluca Wiktor-Jedrzejczak, Wieslaw Carpenter, Nancy Mehta, Bhakti Franklin, Janet Giagounidis, Aristoteles